105 related articles for article (PubMed ID: 2338634)
1. Plasma elimination of milrinone in rats in relation to its hemodynamic effects.
Verrijk R; Vleeming W; van Rooij HH; Wemer J; Porsius AJ
J Pharm Sci; 1990 Mar; 79(3):236-9. PubMed ID: 2338634
[TBL] [Abstract][Full Text] [Related]
2. Correlation of the hemodynamic and pharmacokinetic profile of intravenous milrinone in the anesthetized dog.
Alousi AA; Iwan T; Edelson J; Biddlecome C
Arch Int Pharmacodyn Ther; 1984 Jan; 267(1):59-66. PubMed ID: 6721624
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and effects on blood pressure of a single oral dose of milrinone in healthy subjects and in patients with renal impairment.
Larsson R; Liedholm H; Andersson KE; Keane MA; Henry G
Eur J Clin Pharmacol; 1986; 29(5):549-53. PubMed ID: 3956560
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and pharmacodynamics of milrinone lactate in pediatric patients with septic shock.
Lindsay CA; Barton P; Lawless S; Kitchen L; Zorka A; Garcia J; Kouatli A; Giroir B
J Pediatr; 1998 Feb; 132(2):329-34. PubMed ID: 9506650
[TBL] [Abstract][Full Text] [Related]
5. Milrinone and dobutamine in severe heart failure: differing hemodynamic effects and individual patient responsiveness.
Colucci WS; Wright RF; Jaski BE; Fifer MA; Braunwald E
Circulation; 1986 Mar; 73(3 Pt 2):III175-83. PubMed ID: 3510774
[TBL] [Abstract][Full Text] [Related]
6. Acute effects of milrinone on the electrocardiogram and the cardiac hemodynamics of rats with pressure overload-induced congestive heart failure.
Desjardins S; Cauchy MJ
Arch Int Pharmacodyn Ther; 1989; 301():182-99. PubMed ID: 2624514
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and pharmacodynamics of milrinone in chronic congestive heart failure.
Benotti JR; Lesko LJ; McCue JE; Alpert JS
Am J Cardiol; 1985 Oct; 56(10):685-9. PubMed ID: 4050707
[TBL] [Abstract][Full Text] [Related]
8. Positive inotropic and vasodilator actions of milrinone in patients with severe congestive heart failure. Dose-response relationships and comparison to nitroprusside.
Jaski BE; Fifer MA; Wright RF; Braunwald E; Colucci WS
J Clin Invest; 1985 Feb; 75(2):643-9. PubMed ID: 3973022
[TBL] [Abstract][Full Text] [Related]
9. Comparative cardiac effects of milrinone and sodium nitroprusside in conscious rats.
Desjardins S; Cauchy MJ
Drug Chem Toxicol; 1995 Feb; 18(1):43-59. PubMed ID: 7768199
[TBL] [Abstract][Full Text] [Related]
10. The inotropic and hemodynamic effects of intravenous milrinone when reflex adrenergic stimulation is suppressed by beta-adrenergic blockade.
Travill CM; Pugh S; Noble MI
Clin Ther; 1994; 16(5):783-92. PubMed ID: 7859237
[TBL] [Abstract][Full Text] [Related]
11. Hemodynamic profile of BM 14.478: a new positive inotropic and vasodilating agent.
Müller-Beckmann B; Sponer G; Strein K; Bartsch W
J Cardiovasc Pharmacol; 1988 Jan; 11(1):1-7. PubMed ID: 2450246
[TBL] [Abstract][Full Text] [Related]
12. Comparative effects of inotropic agents on coronary and systemic hemodynamics of conscious dogs: actions of milrinone, dopamine, ouabain and MCI-154.
Al-Wathiqui MH; Shimshak TM; Brooks HL; Preuss KC; Wynsen JC; Gross GJ; Warltier DC
Pharmacology; 1988; 36(4):217-27. PubMed ID: 3380877
[TBL] [Abstract][Full Text] [Related]
13. Comparisons of the depressor, inotropic and renal effects of milrinone and CI-930 to different pure vasodilators and diuretics in conscious instrumented dogs.
Lee KC; Clas DM; Gorczyca WP; Silver PJ; Ezrin AM
Drugs Exp Clin Res; 1991; 17(7):323-36. PubMed ID: 1686584
[TBL] [Abstract][Full Text] [Related]
14. Physiologic assessment of the inotropic, vasodilator and afterload reducing effects of milrinone in subjects without cardiac disease.
Borow KM; Come PC; Neumann A; Baim DS; Braunwald E; Grossman W
Am J Cardiol; 1985 Apr; 55(9):1204-9. PubMed ID: 3984901
[TBL] [Abstract][Full Text] [Related]
15. Positive inotropic effects of milrinone, sulmazole and AR-L100 on isolated normal and infarcted hearts of the rat.
Verrijk R; Vleeming W; van Rooij HH; Wemer J; Porsius AJ
Arch Int Pharmacodyn Ther; 1989; 297():7-17. PubMed ID: 2730243
[TBL] [Abstract][Full Text] [Related]
16. Beneficial hemodynamic effects of two weeks' milrinone treatment in conscious rats with heart failure.
Schoemaker RG; Debets JJ; Struyker-Boudier HA; Smits JF
Eur J Pharmacol; 1990 Jul; 182(3):527-35. PubMed ID: 2226621
[TBL] [Abstract][Full Text] [Related]
17. Separation of the direct myocardial and vasodilator actions of milrinone administered by an intracoronary infusion technique.
Ludmer PL; Wright RF; Arnold JM; Ganz P; Braunwald E; Colucci WS
Circulation; 1986 Jan; 73(1):130-7. PubMed ID: 3940664
[TBL] [Abstract][Full Text] [Related]
18. Effects of milrinone on coronary hemodynamics and myocardial energetics in patients with congestive heart failure.
Monrad ES; Baim DS; Smith HS; Lanoue A; Brauwald E; Grossman W
Circulation; 1985 May; 71(5):972-9. PubMed ID: 3986984
[TBL] [Abstract][Full Text] [Related]
19. Regional blood flow and neurohormonal responses to milrinone in congestive heart failure.
Cody RJ; Kubo SH; Covit AB; Müller FB; Rutman H; Leonard D; Laragh JH; Feldschuh J; Preibisz J
Clin Pharmacol Ther; 1986 Feb; 39(2):128-35. PubMed ID: 3510799
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of intravenous milrinone in patients undergoing cardiac surgery.
Bailey JM; Levy JH; Kikura M; Szlam F; Hug CC
Anesthesiology; 1994 Sep; 81(3):616-22. PubMed ID: 8092507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
